we are light
Luminous Futures invests, advises and supports projects that seek to improve human life in alignment with our divine home, planet Earth.
We look inward to become more coherent with the wisdom that exists in nature and within us all. We look outward to develop more equitable and regenerative economic systems and ways of being.
We support projects aiding in the creation of resilient and globally accessible economic systems.
Orbital is an end-to-end platform to send, receive and convert traditional, exotic and digital asset payment flows. They focus on facilitating seamless B2B cross-border payments with an emphasis on emerging markets.
Fuel is the world’s fastest execution layer for the modular blockchain stack. Fuel focuses on abstracting away the common pain points for crypto users and developers while delivering maximum security and the highest flexible throughput.
HIFI Bridge develops payment and checkout infrastructure to connect blockchain to the world. Their platform helps increase access to quality financial tools and resources by allowing businesses to easily transact with cryptocurrencies, trade digital assets, and connect their business accounts all-in-one.
STIX is the premier OTC platform for secondaries in the digital assets markets. They are building key infrastructure for the growth of the digital economy by helping facilitate seamless illiquid token transactions.
KINO makes it possible for anyone to invest in and experience Hollywood movies through the use of blockchain technology. They finance films in a way that makes the industry more equitable, gives artists and filmmakers proper compensation for their work and ensures a higher portion of the profits.
We support biotech projects that help humans to become more adaptable and reduce unnecessary pain and suffering.
PanaSea have developed the first scalable sea cucumber aquaculture system on the planet. Sea cucumbers are not only a delicacy in China but a critical member of the marine biodiversity, boosting the health of the ecosystem by de-acidifying oceans.
Oisin Biotechnologies have developed their patented Fusogenix lipid nanoparticle (LNP) which targets the genes of ‘zombie cells' (senescent cells) and effectively causes them to ‘commit suicide’ (autophagy). Evidence suggests a reduction of senescent cells also helps reduce potential age related diseases.
OncoSenX are working to develop next generation cancer therapies that will be more targeted with less side effects. They utilise more precise genetic information tools, such as Oisin Biotechnologies Fusogenix LNP, to attack solid tumour and metastatic cancer cells in a less invasive manner.
Leucadia Therapeutics work on a new approach to treat and prevent Alzheimer’s disease. Their patented Arethusta technology improves the clearance of toxic metabolites from the earliest regions of the brain, curing mild cognitive impairment (MCI) and, potentially, Alzheimer's disease.
Viscient Biosciences have created a system to test drugs in 3D models of cells which mimics the animal testing phases of drug development. This will accelarate the drug delivery pipeline and reduce the testing on animals. Viscient are initially targeting NASH (non-alcoholic steatohepatitis), the ‘fatty liver disease’.
Octarine is a fermentation technology platform that provides environmentally friendly bio ingredients like bio based natural colours, to be enhanced and produced at scale. This innovative process reduces pollution and increases efficiency of production.
Nuchido Laboratories apply a holistic approach to the aging systems of the human body. Their recent clinical trial data on Nuchido’s supplement Time+ supports that it increases NAD+, Sirt1 and the AMPK pathways, all of which are known to help reduce biological age in humans.